Results 131 to 140 of about 178,306 (248)
S268: INTERIM ANALYSIS OF A PHASE 2 TRIAL TO ASSESS THE EFFICACY AND SAFETY OF CRIZANLIZUMAB IN SICKLE CELL DISEASE PATIENTS WITH PRIAPISM (SPARTAN)
HemaSphere, 2023 Alan Anderson, Fuad El Rassi, Michael R. Debaun, Modupe Idowu, Julie Kanter, Soheir Adam, Susanna Curtis, Darla Liles, Biree Andemariam, Morgan L. Mclemore, Robert Sheppard Nickel, Poornima Ramadas, Jincy Paulose, Dram Laine, Mahmudul Khan, Deepika Darbari, Arthur L. Burnett +16 moredoaj +1 more sourceIntentional and unintentional nonadherence to hydroxyurea among people with sickle cell disease: a qualitative study [PDF]
, 2020 Jason Hodges, Shannon Phillips, Sarah Norell, Chinonyelum Nwosu, Hamda Khan, Lingzi Luo, Sherif M. Badawy, Allison A. King, Paula Tanabe, Marsha Treadwell, Lucia Rojas Smith, Cecelia Calhoun, Jane S. Hankins, Jerlym S. Porter +13 moreopenalex +1 more sourceTranscutaneous electrical nerve stimulation (TENS) for pain management in sickle cell disease [PDF]
, 2017 Abas, Adinegara B.L., Ballas, Samir K., Dixit, Ruchita, Godinho, Myron A., Moe, Soe, Pal, Sudipta, Ram, Shanker, Yousuf, Uduman A.M. +7 morecore +2 more sourcesElevated transpulmonary gradient and cardiac magnetic resonance-derived right ventricular remodeling predict poor outcomes in sickle cell disease
Haematologica, 2016 Kim-Lien Nguyen, Xin Tian, Shoaib Alam, Alem Mehari, Steve W. Leung, Catherine Seamon, Darlene Allen, Caterina P. Minniti, Vandana Sachdev, Andrew E. Arai, Gregory J. Kato +10 moredoaj +1 more source